LIXTE Biotechnology Transforms into AI Energy Infrastructure Platform, Adds Denham Capital Founder to Board
LIXTE Biotechnology Holdings announces a strategic pivot to an AI energy infrastructure company, appointing Denham Capital founder Stuart D. Porter to its board, while seeking a buyer for its cancer-treatment operations.
